Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis. - Wikidata - wikimedia - TriplyDB

Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.

Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.

http://www.wikidata.org/entity/Q37002594

about

An isothermal DNA amplification method for detection of Onchocerca volvulus infection in skin biopsies Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes.Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal.A novel rapid test for detecting antibody responses to Loa loa infections.O-5S quantitative real-time PCR: a new diagnostic tool for laboratory confirmation of human onchocerciasis.Comparison of Platforms for Testing Antibody Responses against the Chlamydia trachomatis Antigen Pgp3.Onchocerciasis: shifting the target from control to elimination requires a new first-step-elimination mapping.Interruption of onchocerciasis transmission in Bioko Island: Accelerating the movement from control to elimination in Equatorial Guinea.Onchocerciasis-associated epilepsy: From recent epidemiological and clinical findings to policy implications.Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.Transitioning from river blindness control to elimination: steps toward stopping treatment.Onchocerca volvulus infection in Tihama region - west of Yemen: Continuing transmission in ivermectin-targeted endemic foci and unveiled endemicity in districts with previously unknown status.Mansonella perstans, Onchocerca volvulus and Strongyloides stercoralis infections in rural populations in central and southern Togo.Rethinking the serological threshold for onchocerciasis elimination.

P2860

Q28818096-5DD4B221-F1FC-4A05-AB33-57184F68E1F8 Q36257358-D92F7F4C-9E39-417B-9433-7D9470906E71 Q36303283-47B4AE0A-0A1B-452D-9A0E-F22406F5A27E Q39346014-E735F171-7656-4B84-9DC0-6226FD27C8EE Q41992060-D07D0597-8A31-4C1B-8ED5-498AA840505F Q43924390-4550C094-AE85-4F3A-B076-27A4F064842C Q52689691-87CD067A-F738-4B34-837B-4FCEAFCDC416 Q53686526-E9EF8F85-BB22-45F1-8616-39880677DD90 Q53697858-B3AA40CE-2505-4F01-8ACC-7A7EAC385C60 Q53701529-29D1BE0B-B90A-48B3-AD15-58F9855A2CE1 Q53702860-ADEAB8E8-1892-4586-B015-DC73311913C1 Q54262173-970C6D7B-F006-4A1A-9CF5-6B1C96B72594 Q55133116-D6F32180-2726-490D-8EF4-8CA2B7C10F2F Q55209417-BFC3F466-3F67-4E8E-8E5B-4044361C306F

P2860

Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.

http://www.wikidata.org/entity/Q37002594

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.

@en

Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.

@nl

type

label

Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.

@en

Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.

@nl

prefLabel

Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.

@en

Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.

@nl

P1433

Q37002594-B0DF10F4-A4B6-48C9-B724-8F58C18CE1F1

P1476

Q37002594-689632D4-2231-4FE6-9A4A-FDEFB32F0E96

P2093

Q37002594-05676B1A-2AF3-419A-AA6C-556556F42F81

Q37002594-07C01287-B461-4AF8-92FA-0C442B31B3E1

Q37002594-0B2FAC06-A706-42A0-859A-56DE768CEBB6

Q37002594-1B4F6253-32CE-441C-BE7D-EE0382F9024B

Q37002594-1CD64C3A-9FC8-4B1C-A503-152852E3FA21

Q37002594-298AA5B6-6D45-41A2-895F-34B9719314F5

Q37002594-385C6606-62B7-4958-8C15-E7FDD685DA87

Q37002594-3C60DF21-7791-4EC2-BCDE-88ACF5604D40

Q37002594-4069DFB2-3041-4FB8-A780-20932CAC5985

Q37002594-A8CDC334-44BB-410A-9D30-3541E8D5F184

P2860

Q37002594-050CF6C9-0F1B-4DF7-AC37-77C3845D8856

Q37002594-108C6E9B-C5A0-4A12-A6E1-994A1DEA8B71

Q37002594-1289A1F1-8ECC-40FC-8A05-9B6C4B8B7C57

Q37002594-1BA96E30-CD00-4BE5-B0CB-9C6122E534C7

Q37002594-1F55AECC-8FFB-4993-8F13-49143D6168D3

Q37002594-2AF0D0A8-1A5E-488C-9A19-01FAB38C244A

Q37002594-3E47E2B1-D713-4B22-BC49-31A99A463384

Q37002594-45305470-6994-4129-B27B-7EEA7F6A9CEF

Q37002594-47220953-CD60-4FD6-A412-B59DBDF01D91

Q37002594-5062B4D6-84A6-4D02-9196-432047F3A37E

P2888

Q37002594-202DC6D9-385D-4485-A345-EC1AA56355EA

P304

Q37002594-62F4F094-163A-4B22-B78F-448F8730CA38

P31

Q37002594-51A2FD26-91FE-440F-BDD2-5E5DA95797AF

P356

Q37002594-68BFA62A-CFC6-4E96-B8D9-F72ADA13D503

P433

Q37002594-57D0E4C1-76CD-4B2D-A198-B4C50BE22AE7

P478

Q37002594-59391D32-FE97-4EC9-A49B-F40DF7282247

P577

Q37002594-526FF6AA-D687-4B53-9AEC-3BA7DC04E9E1

P6179

Q37002594-4DC10BDB-26D4-4913-94D0-64004AFAB755

P698

Q37002594-F1336614-90AF-4612-B5B5-D8E6DE4BC222

P921

Q37002594-48CD484E-E623-42FC-8F6B-0684CFC7F1AF

Q37002594-A4905950-0CA7-482B-9397-CEA734F54981

P932

Q37002594-4CE97289-D3C9-44B0-B6B2-C02056351E09

P356

S13071-016-1623-1

P1433

Parasites & Vectors

P1476

Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.

@en

P2093

Allison Golden

http://www.w3.org/2001/XMLSchema#string

Dunia Faulx

http://www.w3.org/2001/XMLSchema#string

Eric Stevens

http://www.w3.org/2001/XMLSchema#string

Gonzalo J Domingo

http://www.w3.org/2001/XMLSchema#string

Kangi Adade

http://www.w3.org/2001/XMLSchema#string

Kossi Komlan

http://www.w3.org/2001/XMLSchema#string

Lindsay Yokobe

http://www.w3.org/2001/XMLSchema#string

Michael Kalnoky

http://www.w3.org/2001/XMLSchema#string

Méba Banla

http://www.w3.org/2001/XMLSchema#string

Peter T Soboslay

http://www.w3.org/2001/XMLSchema#string

P2860

Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal

Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.

African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost

Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution

Serology for trachoma surveillance after cessation of mass drug administration

Elimination of Onchocerciasis from Mexico

African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases

Characterisation of nuclear ribosomal DNA sequences from Onchocerca volvulus and Mansonella ozzardi (Nematoda: Filarioidea) and development of a PCR-based method for their detection in skin biopsies.

River blindness: a success story under threat?

Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort study.

P2888

s13071-016-1623-1

P304

338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13071-016-1623-1

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1023492546

http://www.w3.org/2001/XMLSchema#string

P698

27296630

http://www.w3.org/2001/XMLSchema#string

P921

P932

4907250

http://www.w3.org/2001/XMLSchema#string